Pharma material approval process optimisation: source verification, slide redesign, and MLR tagging streamlined

A pharmaceutical brand's Medical Affairs team was experiencing persistent delays in their material review and approval cycle. On average, materials were going through 3–4 rounds of medical-legal-regulatory review before clearance — a process that should have taken 2–3 weeks was taking 6–8 weeks per document.

An internal review identified the root causes: source documents were not consistently cited to the specific data points they supported; references were not formatted to the standard expected by the MLR team; slides contained claims without clear evidentiary backup; and the tagging system used to associate claims with source documents was inconsistently applied.

The problem was not the approval process — it was the quality of the materials entering it. Every returned document created rework, re-review, and additional delays. The team was spending more time managing the approval cycle than producing new materials.

MLR is not a bureaucratic obstacle. It is a quality gate. Materials that fail it are materials that were not compliance-ready when they were submitted. The solution is upstream, not in the review cycle itself.